Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?
- PMID: 23597717
- DOI: 10.1016/j.vaccine.2013.04.009
Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?
Abstract
Background: Healthcare provider (HCP) reporting to the Vaccine Adverse Event Reporting System (VAERS) is important to assuring the safety of U.S. licensed vaccines. HCP awareness of and practices regarding reporting of adverse events following immunization (AEFI) is understudied.
Methods: A large, nationally representative sample of U.S. office-based HCP across three occupational groups (physicians, mid-level providers [physician assistants, advanced practice nurses] and nurses) and three primary care practice areas (pediatrics, family medicine, internal medicine) were surveyed utilizing standardized methodology. We assessed HCP familiarity with VAERS, the situations under which they were likely to report an AEFI, and the methods they used and preferred for reporting. We used logistic regression to determine factors associated with HCP not reporting AEFI to VAERS.
Results: Our survey response rate was 54.9%. The percentage of HCP aware of VAERS (71%) varied by occupation and primary care practice area. About 37% of HCP had identified at least one AEFI with only 17% of these indicating that they had ever reported to VAERS. More serious events were more likely to be reported. Factors associated with HCP not reporting AEFI included: HCP not familiar versus very familiar with filing a paper VAERS report (OR=12.84; p<0.0001), primary care practice area of internal medicine versus pediatrics (OR=4.22; p=0.0005), and HCP not familiar versus very familiar with when it was required to file a VAERS report (OR=5.52; p=0.0013).
Conclusions: Specific educational interventions targeted to HCP likely to see AEFI but not currently reporting may improve vaccine safety reporting practices.
Published by Elsevier Ltd.
Similar articles
-
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22. Vaccine. 2015. PMID: 26209838 Free PMC article. Review.
-
Military healthcare providers reporting of adverse events following immunizations to the vaccine adverse event reporting system.Mil Med. 2014 Apr;179(4):435-41. doi: 10.7205/MILMED-D-13-00391. Mil Med. 2014. PMID: 24690969 Free PMC article.
-
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Vaccine. 2012 Nov 26;30(50):7253-9. doi: 10.1016/j.vaccine.2012.09.074. Epub 2012 Oct 9. Vaccine. 2012. PMID: 23063829
-
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.Pediatr Infect Dis J. 2004 Apr;23(4):287-94. doi: 10.1097/00006454-200404000-00002. Pediatr Infect Dis J. 2004. PMID: 15071280 Review.
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
Cited by
-
CDC COVID-19 Vaccine Pregnancy Registry: Design, data collection, response rates, and cohort description.Vaccine. 2024 Mar 7;42(7):1469-1477. doi: 10.1016/j.vaccine.2023.11.061. Epub 2023 Dec 6. Vaccine. 2024. PMID: 38057207 Free PMC article. Review.
-
Barriers to optimal AEFI surveillance and documentation in Nigeria: Findings from a qualitative survey.PLOS Glob Public Health. 2023 Sep 8;3(9):e0001658. doi: 10.1371/journal.pgph.0001658. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37682847 Free PMC article.
-
Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.PLoS One. 2023 Feb 17;18(2):e0281993. doi: 10.1371/journal.pone.0281993. eCollection 2023. PLoS One. 2023. PMID: 36800368 Free PMC article.
-
What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector.Vaccine. 2023 Jan 4;41(1):263-273. doi: 10.1016/j.vaccine.2022.11.054. Epub 2022 Nov 25. Vaccine. 2023. PMID: 36456389 Free PMC article.
-
Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.Front Public Health. 2022 Oct 13;10:972464. doi: 10.3389/fpubh.2022.972464. eCollection 2022. Front Public Health. 2022. PMID: 36311588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous